Trial intelligence / Profile preview

Dexmedetomidine vs pethidine for prevention of postoperative shivering in elective lower limb surgery

IRCT20241022063464N2Phase 3Completed

Sponsor
Golestan University of Medical Sciences
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in postanesthetic shivering (PAS) comparing Dexmedetomidine with Pethidine (2 arms). Primary endpoint: Incidence of postoperative shivering. Started May 2025; status: completed.

02

Drugs

dexmedetomidinepethidine
03

Conditions

postanesthetic shivering (PAS)

Beyond the preview

Go deeper on IRCT20241022063464N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241022063464N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call